- Health A to Z
Healthline Premium Tools
Advertisement
Marketplace
|
Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases , part of the National Institutes of Health.
|
|
... U.S. already has single payer care, not only for the aged (Medicare) and the poor (Medicaid) but also for patients with end-stage renal disease (kidney failure) who need dialysis or a transplant. Nix has a unique perspective on Medicare ESRD, as the ...
|
|
Dynavax Technologies Corporation announced the initiation of a Phase 3 registration trial for HEPLISAVTM hepatitis B vaccine in individuals with chronic kidney disease.
|
|
The Centers for Medicare & Medicaid Services today proposed a new prospective payment system for facilities that provide dialysis services to Medicare beneficiaries who have end-stage renal disease .
|
|
... vascular graft of its kind on the market approved for hemodialysis access and the treatment of Peripheral Artery Disease (PAD). This unique surgical graft is designed to address the gap in clinical performance between prosthetic and autologous vein ...
|
|
Shedding some excess weight through diet, exercise or surgery may help obese adults with kidney disease ward off further decline in kidney function, research hints.
|
|
Decades ago, Congress mandated that Medicare cover the treatment of end-stage renal disease , including dialysis and transplants, for most patients in the US.
|
|
Early identification of individuals with chronic kidney disease can delay the onset of end stage renal disease and the need for chronic dialysis treatments.
|
|
Early identification of individuals with chronic kidney disease can delay the onset of end stage renal disease and the need for chronic dialysis treatments.
|
|
Early identification of individuals with chronic kidney disease can delay the onset of end stage renal disease and the need for chronic dialysis treatments.
|
|
... discussions with potential partners. We believe this progress, which could generate preliminary swine flu data by year's end, helps make the Company more attractive to potential partners." Webber continued: "We rate AEMD a 'Speculative Buy' with a ...
|
|
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration has removed the clinical hold for the HEPLISAVTM Investigational New Drug application in individuals with chronic kidney disease.
|
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2009 Healthline Networks, Inc. All rights reserved.